Acelyrin, Inc. (SLRN)

NASDAQ: SLRN · IEX Real-Time Price · USD
5.02
-0.12 (-2.33%)
At close: Apr 17, 2024, 4:00 PM
4.990
-0.030 (-0.60%)
After-hours: Apr 17, 2024, 5:45 PM EDT
-2.33%
Market Cap 488.64M
Revenue (ttm) n/a
Net Income (ttm) -381.64M
Shares Out 97.34M
EPS (ttm) -5.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 586,356
Open 5.20
Previous Close 5.14
Day's Range 4.98 - 5.35
52-Week Range 4.98 - 29.88
Beta n/a
Analysts Buy
Price Target 23.67 (+371.51%)
Earnings Date Mar 28, 2024

About SLRN

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date May 5, 2023
Employees 51
Stock Exchange NASDAQ
Ticker Symbol SLRN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for SLRN stock is "Buy." The 12-month stock price forecast is $23.67, which is an increase of 371.51% from the latest price.

Price Target
$23.67
(371.51% upside)
Analyst Consensus: Buy
Stock Forecasts

News

ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights

Reported positive Phase 1/2 proof-of-concept data for lonigutamab, first subcutaneous anti-IGF-1R to demonstrate clinical responses in thyroid eye disease patients

20 days ago - GlobeNewsWire

ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis

Study met primary endpoint of ACR50 at 16 weeks versus placebo with high statistical significance and is expected to be the first of two registrational trials in psoriatic arthritis

5 weeks ago - GlobeNewsWire

ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients

Dose ordered and robust HiSCRs were rapidly demonstrated with about a third of patients achieving HiSCR100, or resolution of abscesses and nodules, by week 16 and through week 32

5 weeks ago - GlobeNewsWire

ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications

Highly accomplished leader bringing more than 25 years of investor relations, communications, and operational & strategic finance experience at public healthcare companies

2 months ago - GlobeNewsWire

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Acelyrin, Inc.(SLRN) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Jan. 16, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acelyrin, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN) of a class action securities lawsuit. CLASS DEFINITION:...

3 months ago - PRNewsWire

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or ...

3 months ago - Accesswire

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or ...

3 months ago - Accesswire

FINAL SLRN DEADLINE: Bronstein, Gewirtz & Grossman LLC Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, Jan. 15, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed again...

3 months ago - PRNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acelyrin, Inc. of Class Action Lawsuit and Upcoming Deadline - SLRN

NEW YORK , Jan. 14, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Acelyrin, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN) and certain officers. Th...

3 months ago - PRNewsWire

SLRN Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Acelyrin, Inc. (SLRN) of Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa. , Jan. 12, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Acelyrin, Inc. (...

3 months ago - PRNewsWire

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN)

NEW YORK , Jan. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Acelyrin, Inc.. Shareholders who purchased shares of SLRN during the class period listed are ...

3 months ago - PRNewsWire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or ...

3 months ago - Accesswire

SLRN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK , Jan. 11, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed agai...

3 months ago - PRNewsWire

ACELYRIN INVESTOR DEADLINE APPROACHING

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Acelyrin To Contact Him Directly To Discuss Their Options If you suffered losses exceedi...

3 months ago - PRNewsWire

SLRN Investors Have Opportunity to Lead ACELYRIN, Inc. Securities Fraud Lawsuit

LOS ANGELES , Jan. 11, 2024 /PRNewswire/ --  Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit aga...

3 months ago - PRNewsWire

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Acelyrin Investors of a Lead Plaintiff Deadline of January 16, 2024

NEW YORK, Jan. 11, 2024 /PRNewswire/ -- Attention Acelyrin, Inc. ("Acelyrin") (NASDAQ: SLRN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf ...

3 months ago - PRNewsWire

FINAL DEADLINE THIS MONTH: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or "...

3 months ago - Accesswire

Final Deadline Approaching for SLRN Investors: Kessler Topaz Meltzer & Check, LLP Reminds Acelyrin, Inc. (SLRN) Investors of Class Action Lawsuit Deadline on January 16, 2024

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Acelyrin, Inc. ...

3 months ago - Business Wire

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or "...

3 months ago - Accesswire

ACELYRIN INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Acelyrin To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $50,000 investing in Acelyrin securities between May 4, 2023 and September 11, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...

3 months ago - PRNewsWire

SHAREHOLDER ACTION DEADLINE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or "...

3 months ago - Accesswire

ROSEN, A LEADING NATIONAL FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLRN

NEW YORK , Jan. 1, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, ...

3 months ago - PRNewsWire

SLRN CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Acelyrin, Inc. (SLRN)

RADNOR, Pa. , Dec. 29, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been against Acelyrin, Inc. ...

3 months ago - PRNewsWire

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 29, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acelyrin, Inc. ("Acelyrin" or...

3 months ago - Accesswire

ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acelyrin, Inc. of Class Action Lawsuit and Upcoming Deadline - SLRN

NEW YORK , Dec. 28, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Acelyrin, Inc. ("Acelyrin" or the "Company") (NASDAQ: SLRN) and certain officers. Th...

3 months ago - PRNewsWire